SIOX | Sio Gene Therapies Inc
Category: Consumer goods
Quick infos Headquarters: Hamilton, Bermuda Trade prices Volume: Market Cap: 155.10M Prev closed: 2.64 Open: 2.66 High: 2.78 Low: 2.52 52 week low: 1.41 52 week high: 5.74 Dividends: No Dividends Next ER: August 10, 2023 Before Market Opens
About the Company Sio Gene Therapies, formerly known as Axovant Gene Therapies, is a clinical-stage pharmaceutical company that develops gene therapies to treat neurological disorders. The company is headquartered in New York City and is incorporated in Basel, Switzerland.
Earnings History Date EPS / Forecast Revenue / Forecast November 10, 2023 August 10, 2023 - / -0.06- / -June 28, 2023 - / -0.1428- / -June 13, 2023 - / -0.1428- / -February 14, 2023 -0.05 / -0.1669- / -view more
Historical Data Date Price Open High Low Vol Change ER May 26, 2023 0.4 0.41 0.41
0.4
64.3K -2.44% May 25, 2023 0.41 0.4 0.41
0.4
102K 0% May 24, 2023 0.41 0.4 0.41
0.4
62.6K 0% May 23, 2023 0.41 0.4 0.41
0.4
24.6K 0% May 22, 2023 0.41 0.4 0.41
0.4
6.6K 0% May 19, 2023 0.41 0.4 0.41
0.4
35.3K 0% May 18, 2023 0.41 0.4 0.41
0.4
29.1K 2.50% May 17, 2023 0.4 0.4 0.41
0.4
49.7K 0% May 16, 2023 0.4 0.4 0.41
0.4
94.2K 0% May 15, 2023 0.4 0.4 0.41
0.4
150K 0% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:October 2014 Employees:38 News
Analyst Rating: Will Sio Gene Therapies Inc (SIOX) Stock Outperform the Market? investorsobserver.com Feb 20, 2021 4:38 pm Sio Gene Therapies EPS beats by $0.09 seekingalpha.com Feb 9, 2021 8:12 pm Another Elon Musk Dogecoin Tweet Sends Speculators Aflutter benzinga.com Feb 6, 2021 4:38 pm Dosing Underway In Sio Gene's Early-Stage Trial For GM2 ... benzinga.com Feb 6, 2021 4:38 pm Should You Buy Sio Gene Therapies Inc (SIOX) Stock Thursday? investorsobserver.com Feb 6, 2021 4:38 pm Sio Gene Therapies secures $11.6M from sale of Arvelle Therapeutics seekingalpha.com Feb 4, 2021 8:19 pm Pre-market Movers In Healthcare Sector: SIOX, CLVS, SENS, AGTC, AXDX… nasdaq.com Jan 27, 2021 4:38 pm What Is The Ownership Structure Like For Sio Gene Therapies ... simplywall.st Jan 27, 2021 4:38 pm Passage Bio receives Citi upgrade on recent weakness seekingalpha.com Jan 26, 2021 5:37 am Did Sio Gene Therapies, Inc. (NASDAQ:SIOX) Insiders Buy Up ... simplywall.st Nov 19, 2020 Sio Gene Therapies to sell Arvelle stake to Angelini Pharma seekingalpha.com Jan 4, 2021 9:33 pm Sio Gene Therapies soars 45% on positive AXO-AAV-GM1 data in nerve cell disorder seekingalpha.com Dec 16, 2020 5:19 pm Sio Gene advances early-stage study of nerve cell disorder gene therapy candidate seekingalpha.com Dec 2, 2020 8:25 pm Axovant Gene Therapies to become Sio Gene Therapies November 13 seekingalpha.com Nov 10, 2020 8:47 pm Axovant on go with pivotal study of gene therapy for rare inherited lipid disorders seekingalpha.com Nov 9, 2020 9:42 pm Axovant sees delayed enrollment in Parkinson’s study with gene therapy seekingalpha.com Oct 30, 2020 5:52 am Axovant nabs Rare Pediatric Disease tag for AXO-AAV-GM2 in rare neurodegenerative disorder seekingalpha.com Oct 13, 2020 9:17 pm Axovant Gene Therapies candidate nabs Rare Pediatric Disease tag for nerve cell disorder seekingalpha.com Oct 9, 2020 7:14 pm New commercial chief at Axovant Gene Therapies seekingalpha.com Oct 8, 2020 8:03 pm Axovant under pressure after selectively reporting gene therapy data in Parkinson's seekingalpha.com Oct 6, 2020 7:40 pm This company doesn't provide a dividend.
Key Persons CEO : Pavan Cheruvu (8 Feb 2018–) Talk about Sio Gene Therapies Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
